60 results
PRE 14A
SHPH
Shuttle Pharmaceuticals Holdings Inc
10 Jun 24
Preliminary proxy
6:12am
amendments to, or grant any waivers from, the code of business conduct and ethics for any officer or director, we will disclose the nature of such amendment
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
, the age and condition of the patients, the stage and severity of disease, the nature of the protocol, the proximity of patients to clinical sites … will undertake or successfully complete any transactions of the nature described above, any transactions that we do complete may be subject to the foregoing
8-K
EX-10.2
SHPH
Shuttle Pharmaceuticals Holdings Inc
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
agree. In the event a suit, action, arbitration, or other proceeding of any nature whatsoever, including, without limitation, any proceeding under the U.S
8-K
EX-10.1
dw87sp9guxby
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
424B3
8pre0l1s2qgp7vjf
24 Aug 23
Prospectus supplement
2:00pm
NT 10-Q
pjbww6z2sxzb6
15 May 23
Notice of late quarterly filing
5:26pm
DEF 14A
muce 8rsnsavatx5
21 Nov 22
Definitive proxy
5:28pm
8-K
EX-3.1
xcgg80afg7sv9
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
8-K
EX-10.1
u1lks5u d18k5ejb2po
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
DRS
i6as33 0pod4v
29 Sep 22
Draft registration statement
12:00am
8-K
p5dhlchkg65q
19 Sep 22
Entry into a Material Definitive Agreement
10:55am
424B4
3uoehy
31 Aug 22
Prospectus supplement with pricing info
6:16am